Abstract 455P
Background
Nutritional status and proper dietary intake have a vital role in cancer prognosis and progression. Alterations in metabolic system due to chemotherapy and cancer can lead to high prevalence of malnutrition. It can be attributable to cancer, therapy effect and decreased food intake. Malnutrition has negative impact on patients treatment, side effects, immunity, Quality of life (QOL) and prolonged hospital stay and expense. Our study aims to assess the nutritional status, timely intervention and QOL in cancer patients undergoing chemotherapy.
Methods
A prospective hospital-based multidisciplinary interventional study was conducted in 97 patients with known histological malignancies who had received chemotherapy as inpatients in oncology wards at Ramaiah hospital in Bangalore for a period of six months. Detailed interview of patients and their care-takers were analysed in structured formats. Malnutrition and QOL were assessed using PG-SGA scale and EORTC QLQ C-30 questionnaire respectively. QOL was assessed at the beginning and at the end of the chemotherapy whereas PG-SGA scale was done for all the cycles and dietary intervention was given to patients who were moderately and severely malnourished. Follow up was done for all the patients till the end of the therapy.
Results
Out of 97 patients 61% were females and 36% were males. During the chemotherapy third cycle 19.5% patients were found to be well nourished (stage A) 63% were moderately malnourished (stage B) and 17.5% were severely malnourished (stage C). After the chemotherapy sixth cycle 60% were in stage A and 34% were in stage B and 6% were in stage C. Qol was also assessed and the total score before and after the chemotherapy was found to be 54.2 + 11.46 and 46.16 + 9.77 respectively Whereas 23% of the patients showed higher score (9.8 + 3.6) in physical domain before the treatment and at the end of the treatment the score increased (22 + 4.1). Emotional domain before treatment (5.9 + 2.5) and after treatment (5.3 + 2.3) social (3.6 + 1.4 and 3.5 + 1.4) cognitive (2.04 + 0.31 and 2.04 + 0.30) and role (5.9 + 1.5 and 3.9 + 1.4).
Conclusions
Pre-emptive assessment of nutritional status and prompt dietary guidance and intervention can improve patient’s nutritional status and QOL.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
Sri Prathima.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
133P - Prognostic and predictive factors from the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in previously treated advanced hepatocellular carcinoma (aHCC)
Presenter: Thomas Yau
Session: Poster display session
Resources:
Abstract
134P - Identification, development and validation of a circulating miRNA-based diagnostic signature for early detection of gastric cancer
Presenter: Daisuke Izumi
Session: Poster display session
Resources:
Abstract
135P - The promising key genes associated with tumour microenvironment and prognosis of hepatocellular carcinoma
Presenter: Jing Fang
Session: Poster display session
Resources:
Abstract
136P - Helicobacter pylori-positive gastric diffuse large B-cell lymphoma: A subset with distinct prognostic features
Presenter: Yuan Cheng
Session: Poster display session
Resources:
Abstract
137P - Significant benefit of pyrotinib combined with SHR6390 in patients with multiline-resistant HER2-positive advanced gastric cancer
Presenter: Zuhua Chen
Session: Poster display session
Resources:
Abstract
138P - Incidence of supracarinal lymph node positivity in operated cases of total esophagectomy: Short term results from a tertiary cancer centre
Presenter: Akhil Palod
Session: Poster display session
Resources:
Abstract
139P - Prognostic usefulness of advanced lung cancer inflammation index in locally-advanced pancreatic carcinoma patients treated with radical chemoradiotherapy
Presenter: Ayberk Besen
Session: Poster display session
Resources:
Abstract
140P - Pancreaticoduodenectomy versus combined neoadjuvant chemotherapy and pancreaticoduodenectomy: Survival patterns among patients with stage II & III periampullary carcinoma
Presenter: Mai Abdelkader
Session: Poster display session
Resources:
Abstract
141P - A 13-gene signature of DNA repair predicts prognosis in gastric cancer patients
Presenter: Jinjia Chang
Session: Poster display session
Resources:
Abstract
142P - Relation between Interleukin -4 (590C/T) gene polymorphism and hepatocellular carcinoma risk in HBV and HCV patients
Presenter: Suzy Gohar
Session: Poster display session
Resources:
Abstract